Integrated solutions, unified teams: Enabling collaboration across the continuum of care
Cardiologists are facing unprecedented growth in structural heart disease (SHD), driven by expanding patient indications, a shift toward less invasive treatment options and Centers for Medicare & Medicaid Services (CMS) policy shifts. This MedAxiom whitepaper, developed with support from Philips, provides a concise, field-informed analysis of how minimally invasive therapies have accelerated the need for transformation of this fast-growing subspecialty of cardiac care.
As volumes increase and procedures extend into mitral, tricuspid and other transcatheter interventions, healthcare providers know that clinical excellence in SHD alone is no longer enough. Program design, collaboration and operational readiness now determine long-term success.
Drawing on insights from high-volume academic centers, the whitepaper distills what separates mature, high-performing SHD programs from those struggling to evolve. It highlights the practical foundations of success: unified valve clinic schedules, early and embedded imaging expertise, standardized care pathways, and the often-underestimated impact of a dedicated registered nurse or advanced practice provider clinic coordinator. These structural decisions translate directly into improved patient flow, more consistent decision-making, reduced variability, shorter length of stay and stronger continuity from referral through follow-up.
The MedAxiom whitepaper offers first-hand, expert guidance for stakeholders across clinical and administrative disciplines to improve multidisciplinary collaboration including:
To proactively advance your SHD program to meet evolving CMS changes and patient care expectations download the whitepaper to read the complete MedAxiom whitepaper for more information.